Walleye Capital
AEHR icon

Walleye Capital’s Aehr Test Systems AEHR Stock Holding History

Walleye Capital’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2K Sell
200
-50,000
-100% -$4.57M ﹤0.01% 4394
2026
Q1 		$1.86M Buy
50,200
+43,500
+649% +$1.39M 0.01% 1528
2025
Q4 		$135K Sell
6,700
-64,400
-91% -$1.56M ﹤0.01% 3739
2025
Q3 		$2.14M Buy
71,100
+37,500
+112% +$812K 0.01% 1519
2025
Q2 		$434K Buy
+33,600
New +$320K ﹤0.01% 2757
2025
Q1 		– Sell
-81,900
Closed -$1.36M – 4173
2024
Q4 		$1.36M Buy
81,900
+22,600
+38% +$301K ﹤0.01% 2115
2024
Q3 		$762K Buy
59,300
+41,600
+235% +$601K ﹤0.01% 2919
2024
Q2 		$198K Sell
17,700
-21,500
-55% -$250K ﹤0.01% 4309
2024
Q1 		$486K Buy
39,200
+22,300
+132% +$372K ﹤0.01% 3222
2023
Q4 		$448K Buy
16,900
+8,700
+106% +$254K ﹤0.01% 3030
2023
Q3 		$375K Sell
8,200
-1,000
-11% -$46.4K ﹤0.01% 3038
2023
Q2 		$380K Buy
9,200
+4,600
+100% +$151K ﹤0.01% 2639
2023
Q1 		$143K Buy
+4,600
New +$148K ﹤0.01% 2719

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Walleye Capital's AEHR Position: Q2 2026 in Review

Walleye Capital reduced its Aehr Test Systems (AEHR) stake by 100% in Q2 2026, selling an estimated $24.4M and leaving 191 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4404.

Walleye Capital first reported a position in AEHR in Q4 2022 and has held it in 9 quarters since. The position peaked at $9.91M in Q1 2026. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Walleye Capital held 191 shares of Aehr Test Systems worth $18.3K as of Q2 2026.
  • Walleye Capital sold 266,996 Aehr Test Systems shares in Q2 2026, an estimated $24.4M.
  • Aehr Test Systems made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4404 holding.
  • Walleye Capital first reported a position in Aehr Test Systems in Q4 2022 and has held it in 9 quarters since.
  • Walleye Capital's Aehr Test Systems position peaked at $9.91M in Q1 2026.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.